ABC: All About Covid-19

  Mankind has come long way from apothecaries and paved its way to the modern drugs and vaccines. Through extensive research led by various renowned scholars the Pharmaceutical industry was established. If the doctors are god, then the ichor is infused by the pharmaceutical industry. Over the period of time the health sector was segregated into private and public health. The privatization of drugs was fueled by the legalization of the intellectual property. This was the beginning of the intellectual property rights support and services which boosted the researchers across the globe. The intellectual property protection refers to creations of the mind, such as inventions; literary and artistic works; designs; and symbols, names and images used in commerce. Intellectual property is protected in law by, for example, patents, which enable people to earn recognition or financial benefit from what they invent or create. The IP rights over a particular product or service gives its inventor

  We’re slowly transitioning into the post-COVID phase, and gearing up to adapt with the fundamental shifts in the way our businesses are going to operate hereupon. The attention, worldwide and across industries, will likely shift towards quickly identifying the most profitable assets, and leveraging them for generating immediate revenues. There will be an ardent need for companies to understand their core assets and predict value of their patent portfolios, so that, they could leverage these insights and identify opportunities to monetize through them.   Challenges Before Enterprises    Companies with large and diversified patent portfolios, often struggle in classifying their patents in relation to their core and non-core (or non-aligned) assets. The bigger challenge is to clearly segment these on the basis of their technical potential and commercial value. In the absence of this clarity, companies often fail to capitalize on their most profitable, sought-after or relevant patents –